| RElugolix VErsus LeUprolide Cardiac Trial (NCT05320406) | Emory University | 2022-06-06 |
| Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV (NCT04514484) | National Cancer Institute (NCI) | 2021-11-22 |
| Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer (NCT04981834) | University of Southern California | 2021-10-27 |
| Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion (NCT04976257) | Ryan Kohlbrenner, MD | 2021-10-13 |
| High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma (NCT04945642) | Jonsson Comprehensive Cancer Center | 2021-08-20 |
| An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer (NCT04777071) | University of Washington | 2021-05-17 |
| Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations (NCT04550494) | National Cancer Institute (NCI) | 2021-04-26 |
| Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer (NCT04725903) | Emory University | 2021-02-01 |
| Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial (NCT04513717) | NRG Oncology | 2021-01-21 |
| Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy (NCT04927559) | University of Southern California | 2020-12-18 |
| Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer (NCT04457245) | Jonsson Comprehensive Cancer Center | 2020-08-14 |
| An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate Cancer (NCT04318028) | University of Southern California | 2020-08-11 |
| Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial (NCT04134260) | NRG Oncology | 2020-04-16 |
| Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners (NCT04189770) | M.D. Anderson Cancer Center | 2020-02-26 |
| Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy (NCT04288336) | Mayo Clinic | 2020-01-08 |
| Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913) | City of Hope Medical Center | 2019-12-24 |
| Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery (NCT03899987) | Roswell Park Cancer Institute | 2019-11-29 |
| Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring (NCT04037254) | NRG Oncology | 2019-10-08 |
| Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans (NCT04215029) | M.D. Anderson Cancer Center | 2019-08-27 |
| A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors (NCT03784677) | M.D. Anderson Cancer Center | 2019-07-29 |
| Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study (NCT03707574) | National Cancer Institute (NCI) | 2019-07-16 |
| Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer (NCT03987386) | M.D. Anderson Cancer Center | 2019-05-30 |
| Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer (NCT03581500) | M.D. Anderson Cancer Center | 2019-02-06 |
| EXERCISING TOGETHER for Couples Coping With Cancer (NCT03630354) | OHSU Knight Cancer Institute | 2019-01-18 |
| Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate (NCT03582475) | Jonsson Comprehensive Cancer Center | 2019-01-11 |
| PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery (NCT03218826) | National Cancer Institute (NCI) | 2018-09-24 |
| Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy (NCT03570827) | Mayo Clinic | 2018-05-14 |
| Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer (NCT03177460) | M.D. Anderson Cancer Center | 2017-06-07 |